)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
NextCell Pharma (NXTCL) investor relations material
NextCell Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary24 Jul, 2025
Executive summary
Operating income for Q3 2025 was SEK 2.3 million, mainly from Cellaviva, with net sales of SEK 2.3 million and a net loss after financial items of SEK -10.3 million compared to -8.8 million last year.
For the first nine months, operating income was SEK 8.5 million, net sales SEK 8.3 million, and net loss after financial items SEK -26.5 million, an improvement from -28.7 million year-over-year.
Cash and cash equivalents at the end of Q3 were SEK 16.7 million, down from SEK 20.8 million last year.
Equity ratio improved to 79% from 77% year-over-year.
Strategic partnership with Fujifilm Irvine Scientific and a US patent grant for the MSC prediction algorithm were key milestones.
Financial highlights
Q3 operating income: SEK 2.3 million (Q3 2024: SEK 2.5 million); net sales: SEK 2.3 million (Q3 2024: SEK 2.4 million).
Q3 net loss after financial items: SEK -10.3 million (Q3 2024: SEK -8.8 million); EPS: SEK -0.14 (Q3 2024: SEK -0.26).
Nine-month net loss after financial items: SEK -26.5 million (2024: SEK -28.7 million); EPS: SEK -0.36 (2024: SEK -0.84).
Cash flow from operating activities for Q3: SEK -8.8 million; for nine months: SEK -28.1 million.
Share capital increased to SEK 14.98 million with 73,091,327 shares outstanding as of May 31, 2025.
Outlook and guidance
Funding secured for 2025 and 2026 following a 95% subscription of TO2 warrants and directed share issues, raising SEK 36.6 million before costs.
Focus remains on advancing ProTrans to market, with robust clinical pipeline and strategic partnerships.
One-year data from the ProTrans-Young study expected in H2 2026; QVance to commence customer onboarding in the coming quarter.
How does ProTrans influence immunological markers?
Detail Fujifilm Biosciences collaboration goals.
When is ProTrans-Young study data expected?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next NextCell Pharma earnings date
Q4 202530 Oct, 2025
Next NextCell Pharma earnings date
Q4 202530 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
NextCell Pharma AB is a Swedish biopharmaceutical company specializing in the development of novel stromal cell therapies, primarily focusing on treatments for autoimmune and inflammatory diseases. Its flagship product, ProTrans, targets type 1 diabetes. The company also operates Cellaviva, the largest private stem cell bank in Scandinavia, which stores and processes stem cells from umbilical cords. NextCell Pharma integrates both therapeutic development and biobanking services within its operations. The company is headquartered in Huddinge, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage